Tumor Suppressors Current Events | Tumor Suppressors News | 6
|
| Page
6 of
43 |
857 Results |
|
|
|
Sort By:
Page Views | Date |
Cold Spring Harbor Laboratory scientists discover new gene that prevents multiple types of cancer
A decades-old cancer mystery has been solved by researchers at Cold Spring Harbor Laboratory (CSHL). "We not only found a critical tumor suppressor gene, but have revealed a master switch for a tumor suppressive network that means more targeted and effective cancer therapy in the future," said CSHL Associate Professor Alea Mills, Ph.D.... view more... (2007-02-12)
Patients regain cognitive function after radiation for brain tumors
Patients who suffer from low-grade brain tumors are able to regain normal cognitive function after receiving radiation therapy to shrink their tumor. view more (2005-11-16)
Estrogen-Dependent Switch Tempers Killing Activity of Immune Cells
The sex hormone estrogen tempers the killing activity of a specific group of immune cells, the cytotoxic T cells (CTLs), which are known to attack tumor cells and cells infected by viruses. view more (2009-08-10)
Scientists discover a genetic switch that links animal growth and cancer
Laboratory discoveries by scientists at two universities may lead to new directions in cancer therapy drugs. view more (2006-04-18)
3T MRI plays significant role in detecting prostate cancer, study says
The use of MRI without endorectal coil can detect prostate cancer and provide undistorted images with diagnostic image quality and accurate tumor localization, according to a recent study conducted by researchers from The Ohio State University in Columbus, OH. view more (2008-04-14)
A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?
The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein. view more (2008-03-13)
Paradigm shift: Switch for programmed cell death promotes spread of glioblastoma
Malignant tumors have usually lost their ability to destroy themselves by programmed cell death, or apoptosis. Therefore, tumors are often resistant to chemotherapy or radiation therapy, whose effect is based on forcing tumor cells to commit suicide. view more (2008-03-12)
A new molecular marker of gastric cancer
Gastric cancer (GC) is one of the most common malignancies in the world with a high incidence and death rate. TNM staging system is used worldwide to predict prognosis and direct therapeutic decisions of patients with GC. view more (2009-03-31)
UNC study: Scientists identify chemical compound that may stop deadly brain tumors
Researchers at the University of North Carolina at Chapel Hill School of Medicine have identified a compound that could be modified to treat one of the most deadly types of cancer, and discovered how a particular gene mutation contributes to tumor growth. view more (2009-04-10)
Effective pain treatment for cancer patients?
Cancer patients often suffer from severe pain that cannot be effectively treated with conventional medication. view more (2009-06-26)
First noninvasive technique to accurately predict mutations in human brain tumors
Donald O'Rourke, MD, Associate Professor of Neurosurgery at the University of Pennsylvania School of Medicine and colleagues, were able to accurately predict the specific genetic mutation that caused brain cancer in a group of patients studied using magnetic resonance imaging (MRI). view more (2009-04-21)
Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors. view more (2008-07-29)
Blood-flow metabolism mismatch predicts pancreatic tumor aggressiveness
Researchers from Turku, Finland, have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. view more (2009-08-26)
A tumor of the pancreas mimicked by colonic duplication?
A case of cystic colonic duplication in an adult mimicked a tumor of the pancreas and the diagnosis was established by histopathological examination of the resected specimen after distal pancreatectomy. view more (2008-03-13)
Effective cancer immune therapy through order in the blood vessels
Immune therapies are considered very promising in cancer medicine: Tumor-fighting immune cells are supposed to invade tumor tissue and eliminate cancer cells right there. view more (2008-04-22)
Light reveals breast tumor oxygen status
Light directed at a breast tumor through a needle can provide pathologists with biological specifics of the tumor and help oncologists choose treatment options that would be most effective for that individual patient. view more (2009-04-01)
Tumor cells that border normal tissue are told to leave
The thin, single-cell boundary where a tumor meets normal tissue is the most dangerous part of a cancer according to a new study by scientists at Washington University School of Medicine in St. Louis. view more (2006-01-11)
Mechanisms Involved with Tumor Relapse Identified
Researchers at Virginia Commonwealth University's Massey Cancer Center studying the interaction between the immune system and cancer cells have identified interferon gamma as one of the signaling proteins involved with tumor relapse. view more (2007-03-14)
A longer lasting tumor blocker
On the heels of dismaying reports that a promising antitumor drug could, in theory, shorten patients' long-term survival, comes a promising study by a Japanese team of researchers that suggests a potentially better option. view more (2009-04-28)
Cell's fight against cancer revealed
If anything in cancer biology can be likened to a cage match, this is it: the battle inside the cell walls between LTag, "The Most Amazing Molecule in the Universe," and p53, "The Guardian of the Genome." view more (2006-09-01)
|
|
| Page
6 of
43 |
857 Results |
|
|
|
Sort By:
Page Views | Date |
|
